Hypercalcemia

Hypercalcemia

State exam

State exam

Esophageal surgical conditions: Clinical
Shock
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary adenoma
Hypertension: Clinical
Hypernatremia
Hyperkalemia
Hypokalemia
Hypercalcemia
Potassium sparing diuretics
Hyperprolactinemia
Diffuse parenchymal lung disease: Clinical
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Class II antiarrhythmics: Beta blockers
Atrial flutter
Class IV antiarrhythmics: Calcium channel blockers and others
Premature atrial contraction
Ventricular fibrillation
Class III antiarrhythmics: Potassium channel blockers
Pleural effusion: Clinical
Hypertensive disorders of pregnancy: Clinical
Preeclampsia & eclampsia
Nephritic and nephrotic syndromes: Clinical
Acute kidney injury: Clinical
Membranoproliferative glomerulonephritis
Amyloidosis
Systemic lupus erythematosus (SLE): Clinical
Hemolytic-uremic syndrome
Renal cysts and cancer: Clinical
Serum sickness
Pancreatitis: Clinical
Hypothyroidism and thyroiditis: Clinical
Hyperparathyroidism
Hyperthyroidism
Graves disease
Non-alcoholic fatty liver disease
Laxatives and cathartics
Renin-angiotensin-aldosterone system
Mineralocorticoids and mineralocorticoid antagonists
Approach to chest pain: Clinical sciences
Non-steroidal anti-inflammatory drugs
Autoimmune hemolytic anemia
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Anemia: Clinical
Anemia of chronic disease
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Wilson disease
Jaundice: Clinical
Bleeding disorders: Clinical
Malabsorption syndromes: Pathology review
Leukemia: Clinical
Chronic leukemia
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Clinical
Achalasia
Pituitary tumors: Pathology review
Growth hormone and somatostatin
Growth hormone deficiency
Antidiuretic hormone
Constitutional growth delay
Parathyroid hormone
Adrenocorticotropic hormone
Multiple endocrine neoplasia
Pediatric orthopedic conditions: Clinical
Hypopituitarism: Pathology review
Infertility: Clinical
Pituitary apoplexy
Hypopituitarism
MEN syndromes: Clinical
Turner syndrome
Streptococcus pyogenes (Group A Strep)
Insulin
Intrauterine growth restriction
Thiazide and thiazide-like diuretics
Anticoagulants: Direct factor inhibitors
Congestive heart failure: Clinical sciences
Chronic kidney disease
Chronic venous insufficiency
Chronic kidney disease: Clinical
Cirrhosis: Clinical
Venous thromboembolism: Clinical
Pneumothorax: Clinical
Breast cancer: Clinical
Pericardial disease: Clinical
Lung cancer: Clinical
Cholestatic liver disease
Biliary atresia
Approach to upper abdominal pain: Clinical sciences
Aortic valve disease
Gallbladder disorders: Clinical

Transcript

Watch video only

With hypercalcemia, hyper -means over and -calc- refers to calcium, and -emia refers to the blood, so hypercalcemia means higher than normal calcium levels in the blood, generally over 10.5 mg/dL.

Now, calcium exists as an ion with a double positive charge - Ca2+ - and it’s the most abundant metal in the human body.

So I know what you’re thinking - yeah, we’re all pretty much cyborgs,- Cool, huh?

So about 99% of that calcium is in our bones in the form of calcium phosphate, also called hydroxyapatite.

The last 1% is split so that the majority, about 0.99% is extracellular - which means in the blood and in the interstitial space between cells, and 0.01% is intracellular or inside cells.

High levels of intracellular calcium causes cells to die.

In fact, that’s exactly what happens during apoptosis, also known as programmed cell death.

For that reason, cells end up spending a lot of energy just keeping their intracellular calcium levels low.

Now, calcium gets into the cell through two types of channels, or cell doors, within the cell membrane.

The first type are ligand-gated channels, which are what most cells use to let calcium in, and are primarily controlled by hormones or neurotransmitters.

The second type are voltage-gated channels, which are mostly found in muscle and nerve cells and are primarily controlled by changes in the electrical membrane potential.

So calcium flows in through these channels, and to prevent calcium levels from rising too high, cells kick excess calcium right back out with ATP-dependent calcium pumps as well as Na+-Ca2+ exchangers.

In addition, most of the intracellular calcium is stored within organelles like the mitochondria and smooth endoplasmic reticulum and is released selectively just when it's needed.

Now, the majority of the extracellular calcium is split almost equally between two groups - calcium that is diffusible and calcium that is not diffusible.

Diffusible calcium is separated into two subcategories: free-ionized calcium, which is involved in all sorts of cellular processes like neuronal action potentials, contraction of skeletal, smooth, and cardiac muscle, hormone secretion, and blood coagulation, all of which are tightly regulated by enzymes and hormones.

The other category is complexed calcium, which is where the positively charged calcium is ionically linked to tiny negatively charged molecules like oxalate, which is a small anions that’s normally found in our blood in small amounts.

The complexed calcium forms a molecule that’s electrically neutral and small enough to cross cell membranes, but, unlike free-ionized calcium is not useful for cellular processes.

Finally, though, there’s the non-diffusible calcium which is bound to negatively charged proteins like albumin and globulin, and the resulting protein-calcium complex is too large and charged to cross membranes, leaving this calcium also uninvolved in cellular processes.

When the body’s levels of extracellular calcium change, it’s detected by a surface receptor in parathyroid cells called the calcium-sensing receptor.

This affects the amount of parathyroid hormone that gets released by the parathyroid gland.

The parathyroid hormone gets the bones to release calcium, and gets the kidneys to reabsorb more calcium so it's not lost in the urine and synthesize calcitriol also known as active vitamin D.

Active vitamin D then goes on to increase calcium absorption in the gastrointestinal tract.

All together, these effects help to keep the extracellular levels of calcium within a very narrow range, between 8.5 to 10 mg/dl.

Sometimes, though, total calcium levels in the blood, which includes both diffusible and non-diffusible - blood can vary a bit, depending on the blood's pH and protein levels.

This happens because albumin has acidic amino acids, like glutamate and aspartate, which have some carboxyl groups that are in the form of COO- or COOH.

Overall the balance of COOi and COOH changes based on the pH of the blood.

Now, when there’s a low pH, or acidosis, there are plenty of protons or H+ ions floating around, and a lot of those COO- groups pick up a proton and become COOH.

More COOH groups make albumin more positively charged, and since calcium is positively charged, these two repel each other, and this decreases bound calcium and increases the proportion of free ionized calcium in blood.

So as more protons bind albumin, more free ionized calcium builds up in the blood, and so even though total levels calcium are the same, there’s less bound calcium and more ionized calcium, which remember is important for cellular processes and can lead to symptoms of hypercalcemia.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Calcium block of Na <sup>+</sup> channels and its effect on closing rate" Proceedings of the National Academy of Sciences (1999)
  6. "The diagnosis and management of hypercalcaemia" BMJ (2015)
  7. "Osborn waves in a hypothermic patient" Journal of Community Hospital Internal Medicine Perspectives (2012)